COMPASS Pathways plc (CMPS) Stock Forecast

NASDAQ: CMPSAnalyst ratings, price target and estimates.

CMPS analyst forecast

as of October 17, 2026
Analyst consensus
Strong buy
4.69 / 5 from 16 analysts
Price target
$23.75
average of analyst targets
Upside to target
+120.9%
from the latest close
Next earnings
November 3, 2026
EPS estimate $-0.42
52-week range
$4.94 – $15.19

CMPS analyst ratings

16 analysts
Strong buy
1275%
Buy
319%
Hold
16%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

CMPS price target

Price $10.75Target $23.75
52-week low $4.9452-week high $15.19

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

CMPS earnings per share estimates

COMPASS Pathways plc EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.33−$0.41−$0.25−$0.38+14.0%4
Current fiscal year (2026)−$1.50−$2.28−$1.07−$1.77+14.9%4
Next fiscal year (2027)−$1.43−$1.98−$0.75−$1.50+4.8%3

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

CMPS revenue estimates

COMPASS Pathways plc revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$0$0$00.0%14
Current fiscal year (2026)$0$0$00.0%14
Next fiscal year (2027)$39.7M$0$171.5M0.0%15

CMPS EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

CMPS revenue: reported and forecast

Reported revenueEstimate (average; low–high)

CMPS EPS estimate revisions

COMPASS Pathways plc EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.34−$0.31−$0.38−$0.33−$0.33−4.3%0 up · 1 down
Current fiscal year (2026)−$0.99−$0.99−$1.85−$1.50−$1.50+51.3%0 up · 0 down
Next fiscal year (2027)−$1.06−$1.08−$1.43−$1.43−$1.43+35.6%1 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

CMPS earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; CMPS beat in 6 of 12.

What analysts expect from CMPS

16 analysts cover COMPASS Pathways; their consensus rating is strong buy (4.69 on a 1–5 scale, where 5 is a strong buy). The average price target is $23.75, 120.9% above the latest close of $10.75. Analysts expect earnings of −$1.50 per share for 2026, +14.9% from a year earlier. For 2027 the average estimate is −$1.43 per share on revenue of $39.7 million. COMPASS Pathways beat the EPS estimate in 6 of the last 12 quarters.

Related: CMPS income statement, CMPS key metrics, CMPS chart. See the CMPS stock overview for the latest quote and news.

CMPS forecast FAQ

What is COMPASS Pathways's price target?

The average analyst price target for COMPASS Pathways is $23.75, 120.9% above the latest close of $10.75.

Is COMPASS Pathways a buy, hold or sell?

Of 16 analysts covering COMPASS Pathways, 12 rate it a strong buy, 3 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is COMPASS Pathways's EPS forecast?

Analysts forecast −$1.50 per share for 2026 (range −$2.28 to −$1.07); for 2027 the estimate is −$1.43.

When does COMPASS Pathways report earnings?

COMPASS Pathways is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 before the market opens; the EPS estimate is $-0.42.

Does COMPASS Pathways usually beat earnings estimates?

COMPASS Pathways reported EPS at or above the analyst estimate in 6 of the last 12 quarters.

Medical Care Facilities: forecast